BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boyd A, Duchesne L, Lacombe K. Research gaps in viral hepatitis. J Int AIDS Soc 2018;21 Suppl 2:e25054. [PMID: 29633564 DOI: 10.1002/jia2.25054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Kramvis A. Challenges for hepatitis B virus cure in resource-limited settings in sub-Saharan Africa. Curr Opin HIV AIDS 2020;15:185-92. [PMID: 32141888 DOI: 10.1097/COH.0000000000000619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Baudoin M, Woode ME, Nishimwe ML, Lemoine M, Sylla B, Kouanfack C, Moh R, Seydi M, Rouveau N, Attia A, Lacombe K, Boyer S. Long-term clinical benefits of Sofosbuvir-based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa. Liver Int 2020;40:2643-54. [PMID: 32687669 DOI: 10.1111/liv.14613] [Reference Citation Analysis]
3 Boyd A, Duchesne L, Lacombe K. Research gaps in viral hepatitis. J Int AIDS Soc 2018;21 Suppl 2:e25054. [PMID: 29633564 DOI: 10.1002/jia2.25054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Gantner P, Cotte L, Allavena C, Bani-Sadr F, Huleux T, Duvivier C, Valantin MA, Jacomet C, Joly V, Chéret A, Pugliese P, Delobel P, Cabié A, Rey D; Dat’AIDS Study Group. Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection. PLoS One 2019;14:e0215464. [PMID: 30998789 DOI: 10.1371/journal.pone.0215464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
5 Lynch E, Falq G, Sun C, Bunchhoeung PDT, Huerga H, Loarec A, Dousset JP, Marquardt T, Paih ML, Maman D. Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey. BMC Infect Dis 2021;21:223. [PMID: 33637051 DOI: 10.1186/s12879-021-05826-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lacombe K, Klein MB. The Rocky Road to viral hepatitis elimination: assuring access to antiviral therapy for ALL coinfected patients from low- to high-income settings. J Int AIDS Soc 2018;21 Suppl 2:e25073. [PMID: 29633554 DOI: 10.1002/jia2.25073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]